Outcome of intracranial hemorrhage in infants with congenital factor VII deficiency

Journal of the Medical Association of Thailand

Volumn 85, Issue SUPPL. 4, 2002, Pages

  Chuansumrit, Ampaiwan ^a   Visanuyothin, Nittaya ^b   Puapunwattana, Siriraj ^c   Chaivisuth, Anong ^d   Rasmidat, Patcharawalai ^e   Charoenkwan, Pimlak ^f   Chiemchanya, Surang ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHARAT NAKHON RATCHASIMA HOSPITAL   (Thailand)

^c Department of Science   (Thailand)

^d Paholpolpayuhasena Hospital   (Thailand)

^e Nopparatrajthani Hospital   (Thailand)

^f Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

CNS Bleeding; Factor VII Deficiency

Indexed keywords

BLOOD CLOTTING FACTOR 7A; FRESH FROZEN PLASMA;

ADOLESCENT; ARTICLE; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BLOOD COMPONENT THERAPY; BRAIN HEMORRHAGE; CHILD; CLINICAL ARTICLE; CRANIOTOMY; FEMALE; HEMATOMA; HUMAN; HYDROCEPHALUS; MALE; SEIZURE;

FACTOR VII DEFICIENCY; FEMALE; HUMANS; INFANT, NEWBORN; INTRACRANIAL HEMORRHAGES; MALE; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 0036881437     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Mariani G, Mazzucconi MG. Factor VII congenital deficiency. Clinical picture and classification of the variants. Haemostasis 1983; 13: 169-77.
2. Ragni MV, Levis JH, Spero JA, Hasiba U. Factor VII deficiency. Am J Hematol 1981; 10: 79-88.
3. Peyvandi F, Mannucci PM, Asti D, Abdoullahi M, Dirocco N, Sharifian R. Clinical manifestations in 28 Italian and Iranian patients with severe factor VII deficiency. Haemophilia 1997; 3: 242-6.
4. nd ed. Baltimore, Maryland: Williams & Wilkins, 1998: 773-802.
5. Koehler M, Hellestern P, Pindur G, Wenzel E, von Blohn G. Factor VII half-life after transfusion of a steam-treated prothrombin complex concentrate in a patient with homozygous factor VII deficiency. Vox Sang 1989; 56: 200-1.
6. Mariani G, Mannucci PM, Mazzucconi MG, Capitanio A. Treatment of factor VII deficiency with a new concentrate. Thromb Haemostas 1978; 39: 675-81.
7. Mariani G, Testa MG, Di Paolantanio T, Molskov Bech R, Hedner U, for the ad hoe Study Group. Use of recombinant, activated factor VII in the treatment of congenital factor VII deficiency. Vox Sang 1999; 77: 131-6.
8. Brozovic M, Stirling Y, Harrioks C, North WR, Meade TW. Factor VII in an industrial population. Br J Haematol 1974; 28: 381-91.
9. Wion KL, Kelly D, Summerfield JA, Tuddenham EGD, Lawn RM. Distribution of factor VII in RNA and antigen in human liver and other tissues. Nature 1985; 317: 726-9.
10. Moran M, Kapsner C. Acute renal failure association with elevated plasma oncotic pressure. N Engl J Med 1987; 317: 150-3.
11. Wong WY, Huang WC, Miller R, Mcginty K, Whisnant JK. Clinical efficacy and recovery levels of recombinant FVIIa (Novo Seven) in the treatment of intracranial hemorrhage in severe neonatal FVII deficiency. Haemophilia 2000; 6: 50-4.
12. Marder VJ, Shulman NR. Clinical aspect of congenital factor VII deficiency. Am J Med 1964; 37: 182-94.
13. Chuansumrit A, Pandhawong S, Tardtong P, Isarangkura P. The safe blood components for a hemophilia patient: A case report. Southeast Asian J Trop Med Public Health 1993; 24 (Suppl 1): 198-200.